Value, Affordability, and Decision Making
Efficient decisions about allocating health care budgets require assessment of the effects of health care interventions and the value for money they provide. Decision-making processes leading to funding decisions should be structured and evidence-based.
Value Based Pricing in the UK
7 September 2010
Every country around the globe struggles with attaining an appropriate balance between providing affordable health care and ensuring access to medical advances. In a recent article…
Shedding the Pounds: Obesity Management, NICE Guidance and Bariatric Surgery in England
1 November 2010
In December 2006, the National Institute for Health and Clinical Excellence (NICE) issued guidance for preventing and managing overweight and obesit. Recommendations are step-wise, starting with…
The Publicly Funded Vaccines Market in Australia
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in Australia. It includes observations as to whether and how…
The Publicly Funded Vaccines Market in the UK
1 October 2010
This research reviews how vaccines other than for travel or influenza are evaluated, procured and delivered in the UK. It includes observations as to whether and…
Using QALYs in Cancer: Review of the Methodological Limitations
1 October 2010
Current methods for constructing quality adjusted life year (QALY) measurements may be deficient for cancer patients in three respects: descriptions of health state, valuation of health…
Deliberative Processes in Decisions about Health Care Technologies
1 June 2009
In the UK and elsewhere, choices about how to allocate health care resources are guided not only by economic calculations, but also by social value judgments…
Assessment and Appraisal of Oncology Medicines: NICE’s Approach and International HTA Experience
1 February 2009
Lower usage of cancer medicines in the UK compared to other countries has created questions, including whether the current approach by NICE to assessing cancer medicines…
Medical Research: What’s It Worth?
1 November 2008
Understanding the nature, extent and processes involved in the return on investment in medical research has been largely neglected as an area of serious scientific study.…
New Guidelines for Economic Evaluation in Germany and the United Kingdom: Are We Any Closer to Developing International Standards?
1 November 2008
Australia was the first, in 1993, to make economic evaluation an important component of its decisions about reimbursement of drugs. Since then, several jurisdictions have followed…